Journey Medical (DERM) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$24.9 million.
- Journey Medical's Enterprise Value fell 1088.0% to -$24.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 1088.0%. This contributed to the annual value of -$20.3 million for FY2024, which is 2599.95% up from last year.
- Latest data reveals that Journey Medical reported Enterprise Value of -$24.9 million as of Q3 2025, which was down 1088.0% from -$20.3 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Enterprise Value registered a high of -$17.0 million during Q2 2023, and its lowest value of -$49.1 million during Q4 2021.
- Moreover, its 5-year median value for Enterprise Value was -$24.7 million (2023), whereas its average is -$27.6 million.
- As far as peak fluctuations go, Journey Medical's Enterprise Value plummeted by 49544.02% in 2021, and later surged by 5543.31% in 2023.
- Quarter analysis of 5 years shows Journey Medical's Enterprise Value stood at -$49.1 million in 2021, then skyrocketed by 34.82% to -$32.0 million in 2022, then rose by 14.26% to -$27.4 million in 2023, then rose by 26.0% to -$20.3 million in 2024, then dropped by 22.87% to -$24.9 million in 2025.
- Its Enterprise Value stands at -$24.9 million for Q3 2025, versus -$20.3 million for Q2 2025 and -$21.1 million for Q1 2025.